Bosh sahifa300601 • SHE
add
Shenzhen Kangtai Biological Prods Co Ltd
Yopilish kursi
14,10 ¥
Kunlik diapazon
13,89 ¥ - 14,13 ¥
Yillik diapazon
12,93 ¥ - 23,45 ¥
Bozor kapitalizatsiyasi
15,54 mlrd CNY
Oʻrtacha hajm
12,82 mln
Narx/foyda
102,91
Dividend daromadliligi
-
Asosiy maydon
SHE
Bozor yangiliklari
Moliyaviy axborot
Moliyaviy hisobot
Daromad
Sof foyda
| (CNY) | mar, 2025info | Y/Y qiyosi |
|---|---|---|
Daromad | 645,20 mln | 42,85% |
Joriy xarajat | 424,14 mln | 38,76% |
Sof foyda | 22,43 mln | -58,51% |
Sof foyda marjasi | 3,48 | -70,93% |
Har bir ulushga tushum | — | — |
EBITDA | 127,47 mln | 2,48% |
Amaldagi soliq stavkasi | 17,00% | — |
Balans
Jami aktivlari
Jami passivlari
| (CNY) | mar, 2025info | Y/Y qiyosi |
|---|---|---|
Naqd pul va qisqa investitsiyalar | 219,94 mln | -77,94% |
Jami aktivlari | 14,25 mlrd | -5,10% |
Jami passivlari | 4,57 mlrd | -15,33% |
Umumiy kapital | 9,68 mlrd | — |
Tarqatilgan aksiyalar | 1,12 mlrd | — |
Narxi/balansdagi bahosi | 1,63 | — |
Aktivlardan daromad | 0,86% | — |
Kapitaldan daromad | 1,07% | — |
Pul aylanmasi
Naqd pulning sof oʻzgarishi
| (CNY) | mar, 2025info | Y/Y qiyosi |
|---|---|---|
Sof foyda | 22,43 mln | -58,51% |
Operatsiyalardan naqd pul | -46,30 mln | 39,22% |
Sarmoyadan naqd pul | -65,23 mln | 82,73% |
Moliyadan naqd pul | -98,94 mln | -180,59% |
Naqd pulning sof oʻzgarishi | -210,53 mln | 36,40% |
Boʻsh pul | -2,72 mlrd | -245,41% |
Haqida
Shenzhen Kangtai Biological Products, also known as BioKangtai, is a Chinese biopharmaceutical company that develops, manufactures and markets vaccines and other vaccine products.
Kangtai develops the Minhai COVID-19 vaccine and has the exclusive right to manufacture the Oxford–AstraZeneca COVID-19 vaccine in mainland China. Wikipedia
Tashkil etilgan
8-sen, 1992
Sayt
Xodimlar soni
1 913
